Tetralogic Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tetralogic Pharmaceuticals's estimated annual revenue is currently $2M per year.(i)
  • Tetralogic Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Tetralogic Pharmaceuticals has 13 Employees.(i)
  • Tetralogic Pharmaceuticals grew their employee count by 8% last year.

Tetralogic Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$7.1M4677%N/AN/A
#3
$14.4M9327%N/AN/A
#4
$0.9M60%N/AN/A
#5
$1.6M1043%N/AN/A
#6
$11.5M746%N/AN/A
#7
$0.9M1122%N/AN/A
#8
$3.7M24-8%N/AN/A
#9
$2M1318%N/AN/A
#10
$9.3M602%N/AN/A
Add Company

What Is Tetralogic Pharmaceuticals?

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15-12%N/A
#2
$2.3M15-29%N/A
#3
$0.9M15-6%$122M
#4
$2M1614%N/A
#5
$1.4M167%N/A